In this free webinar, learn about Escherichia coli (E. coli)'s position as the most popular host for recombinant protein production. Attendees will be introduced to the recent advances in the engineering of E. coli for improved recombinant protein production, including novel, in-house technology platforms for expression vector design and secretion in E. coli. Learn how these platforms can reduce the cost-of-goods to produce proteins and peptides. The featured speaker will explore how strain development and excellence in current good manufacturing practice (cGMP) biomanufacturing result in an attractive partnership for customers.

TORONTO, July 30, 2024 /PRNewswire-PRWeb/ -- Discover the latest advancements in strain development for optimizing the production of complex recombinant proteins using Escherichia coli.

E. coli has gained a reputation for being a fast and economical option for expressing complex molecules but not all proteins are the same.

As an increasing number of promising novel drug targets are discovered, many difficult-to-express and harder-to-produce compounds are reaching and subsequently failing in the development phase, demanding a new generation of unique microbial manufacturing solutions.

In this webinar, the expert speaker will discuss how innovative microbial technologies will allow for improved production of recombinant proteins, including therapeutic proteins for new medicinal products.

More specifically, the speaker will present Vectron Biosolutions' recent research using novel, in-house technology platforms for expression vector design and secretion in E. coli. These technologies allow for the cost-efficient production of biologically active proteins, which are then transported out of the cell for simplified downstream processing.

The success of any microbial program with commercial aspirations must be built on an expert strain development strategy with current good manufacturing practices (CGMP) in mind. The speaker will briefly focus on strain development and how biomanufacturing can help create a one-stop shop for next-generation drug developers looking to hit their next milestone.

Register for this webinar today to explore the advancements in strain development for the efficient production of recombinant proteins using Escherichia coli.

Join Dr. Trond Erik Vee Aune, CEO, Vectron Biosolutions AS, for the live webinar on Tuesday, August 20, 2024, at 10am EDT (3pm BST/UK).

For more information, or to register for this event, visit Microbial Expression Optimization: How E. coli Strain Development Innovations are Shaping the Future of Drug Production.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars and digital content to the global life science, food, healthcare and medical device communities. Every year, thousands of industry practitioners (from pharmaceutical, biotechnology, food, healthcare and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps professionals stay current with industry developments, regulations and jobs. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit https://xtalks.com
For information about hosting a webinar visit https://xtalks.com/why-host-a-webinar/

Media Contact

Soumya Shashikumar, Xtalks, +1 (416) 977-6555 x371, skumar@xtalks.com, https://xtalks.com

View original content to download multimedia:https://www.prweb.com/releases/microbial-expression-optimization-how-e-coli-strain-development-innovations-are-shaping-the-future-of-drug-production-upcoming-webinar-hosted-by-xtalks-302209417.html

SOURCE Xtalks